| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 48.67B | 54.09B | 52.86B | 51.76B | 56.60B | 34.72B |
| Gross Profit | 19.39B | 27.75B | 22.31B | 24.03B | 26.81B | 9.67B |
| EBITDA | 31.55B | 28.67B | 34.93B | 36.66B | 35.43B | 15.99B |
| Net Income | 20.43B | 29.43B | 23.44B | 26.14B | 25.75B | 6.30B |
Balance Sheet | ||||||
| Total Assets | 177.43B | 194.60B | 176.56B | 168.08B | 152.09B | 139.69B |
| Cash, Cash Equivalents and Short-Term Investments | 84.08B | 79.03B | 79.40B | 67.90B | 52.94B | 39.60B |
| Total Debt | 12.54B | 10.87B | 21.63B | 30.48B | 36.49B | 46.55B |
| Total Liabilities | 25.18B | 24.98B | 33.97B | 44.10B | 49.34B | 59.17B |
| Stockholders Equity | 152.25B | 169.62B | 142.59B | 123.97B | 102.75B | 80.51B |
Cash Flow | ||||||
| Free Cash Flow | 8.63B | 5.88B | 14.72B | 18.77B | 25.09B | 7.48B |
| Operating Cash Flow | 12.43B | 29.60B | 26.47B | 27.22B | 29.75B | 13.23B |
| Investing Cash Flow | -4.02B | -14.43B | -1.91B | -10.86B | -382.90M | -3.75B |
| Financing Cash Flow | -12.41B | -16.19B | -16.75B | -10.73B | -18.93B | -11.89B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | ₹237.50B | 6.86 | ― | 2.51% | 1.63% | 25.52% | |
74 Outperform | ₹820.05B | 11.68 | ― | 2.94% | 4.41% | 1.06% | |
67 Neutral | ₹814.21B | 3.95 | ― | 3.26% | 1.77% | 167.91% | |
66 Neutral | ₹19.52B | 9.40 | ― | 1.71% | 3.46% | -8.86% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
51 Neutral | ₹259.82B | 67.10 | ― | 2.04% | -6.35% | 3324.95% |